• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性角化不良患者原始造血细胞的特征分析

Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.

作者信息

Goldman Frederick D, Aubert Geraldine, Klingelhutz Al J, Hills Mark, Cooper Sarah R, Hamilton Wendy S, Schlueter Annette J, Lambie Karen, Eaves Connie J, Lansdorp Peter M

机构信息

Department of Pediatrics, Division of Hematology/Oncology, University of Iowa Children's Hospital, Iowa City 52242, USA.

出版信息

Blood. 2008 May 1;111(9):4523-31. doi: 10.1182/blood-2007-10-120204. Epub 2008 Feb 29.

DOI:10.1182/blood-2007-10-120204
PMID:18310499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2343591/
Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow (BM) failure syndrome associated with mutations in telomerase genes and the acquisition of shortened telomeres in blood cells. To investigate the basis of the compromised hematopoiesis seen in DC, we analyzed cells from granulocyte colony-stimulating factor mobilized peripheral blood (mPB) collections from 5 members of a family with autosomal dominant DC with a hTERC mutation. Premobilization BM samples were hypocellular, and percentages of CD34(+) cells in marrow and mPB collections were significantly below values for age-matched controls in 4 DC subjects. Directly clonogenic cells, although present at normal frequencies within the CD34(+) subset, were therefore absolutely decreased. In contrast, even the frequency of long-term culture-initiating cells within the CD34(+) DC mPB cells was decreased, and the telomere lengths of these cells were also markedly reduced. Nevertheless, the different lineages of mature cells were produced in normal numbers in vitro. These results suggest that marrow failure in DC is caused by a reduction in the ability of hematopoietic stem cells to sustain their numbers due to telomere impairment rather than a qualitative defect in their commitment to specific lineages or in the ability of their lineage-restricted progeny to execute normal differentiation programs.

摘要

先天性角化不良(DC)是一种遗传性骨髓衰竭综合征,与端粒酶基因突变以及血细胞中端粒缩短有关。为了探究DC中造血功能受损的基础,我们分析了来自一个患有常染色体显性DC且携带hTERC突变的家族中5名成员的粒细胞集落刺激因子动员的外周血(mPB)样本中的细胞。动员前的骨髓样本细胞减少,4名DC受试者的骨髓和mPB样本中CD34(+)细胞的百分比显著低于年龄匹配的对照组。因此,直接克隆形成细胞虽然在CD34(+)亚群中以正常频率存在,但绝对数量减少。相比之下,CD34(+) DC mPB细胞中长期培养起始细胞的频率也降低,并且这些细胞的端粒长度也明显缩短。然而,体外成熟细胞的不同谱系数量正常。这些结果表明,DC中的骨髓衰竭是由于造血干细胞因端粒损伤而维持其数量的能力下降所致,而非其向特定谱系分化的定性缺陷,也不是其谱系受限后代执行正常分化程序的能力缺陷。

相似文献

1
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.先天性角化不良患者原始造血细胞的特征分析
Blood. 2008 May 1;111(9):4523-31. doi: 10.1182/blood-2007-10-120204. Epub 2008 Feb 29.
2
p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.p53 介导先天性角化不良症中人类确定性造血失败。
Stem Cell Reports. 2017 Aug 8;9(2):409-418. doi: 10.1016/j.stemcr.2017.06.015. Epub 2017 Jul 27.
3
Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.先天性角化不良和端粒生物学障碍中的骨髓骨骼干/祖细胞缺陷。
Blood. 2015 Jan 29;125(5):793-802. doi: 10.1182/blood-2014-06-566810. Epub 2014 Dec 12.
4
Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.用粒细胞集落刺激因子治疗的正常供体外周血祖细胞采集中存在的长期培养起始细胞的表型和功能特征
Blood. 1996 Sep 15;88(6):2033-42.
5
Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.通过稳定抑制DKC1生成先天性角化不良样造血干细胞。
Stem Cell Res Ther. 2021 Jan 29;12(1):92. doi: 10.1186/s13287-021-02145-8.
6
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.先天性角化不良家族中一种新的常染色体隐性TERT T1129P突变导致细胞衰老及CD34+造血干细胞丢失,mTOR抑制无法使其逆转。
Aging (Albany NY). 2015 Nov;7(11):911-27. doi: 10.18632/aging.100835.
7
Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.先天性角化不良症小鼠模型中加速的造血干细胞衰老对抗氧化治疗有反应。
Aging Cell. 2011 Apr;10(2):338-48. doi: 10.1111/j.1474-9726.2011.00674.x. Epub 2011 Feb 21.
8
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.人DKC1突变诱导多能干细胞的端粒动力学与造血分化
Stem Cell Res. 2019 Oct;40:101540. doi: 10.1016/j.scr.2019.101540. Epub 2019 Aug 20.
9
Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.粒细胞集落刺激因子动员的外周血祖细胞中的原始长期培养起始细胞(LTC-ICs)与稳态骨髓中的原始LTC-ICs具有相似的体外扩增潜力。
Blood. 1997 Jun 1;89(11):3991-7.
10
Dyskeratosis congenita and telomerase.先天性角化不良与端粒酶
Curr Opin Pediatr. 2004 Feb;16(1):23-8. doi: 10.1097/00008480-200402000-00006.

引用本文的文献

1
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells.脂质纳米颗粒可实现高效、无害的人类造血细胞体外基因编辑。
Blood. 2023 Aug 31;142(9):812-826. doi: 10.1182/blood.2022019333.
2
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.编辑 TINF2 作为一种潜在的治疗方法,以恢复先天性角化不良症中的端粒长度。
Blood. 2022 Aug 11;140(6):608-618. doi: 10.1182/blood.2021013750.
3
The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome.骨髓增殖性肿瘤的遗传学特征:胚系变异在定义疾病风险、表型多样性和预后中的作用。
Cells. 2021 Sep 29;10(10):2597. doi: 10.3390/cells10102597.
4
Arhgef2 regulates mitotic spindle orientation in hematopoietic stem cells and is essential for productive hematopoiesis.Arhgef2 调节造血干细胞有丝分裂纺锤体的定向,对于有效的造血作用是必不可少的。
Blood Adv. 2021 Aug 24;5(16):3120-3133. doi: 10.1182/bloodadvances.2020002539.
5
A Case of Presumed Dyskeratosis Congenita Causing Severe Retinal Vascular Occlusion.一例疑似先天性角化不良导致严重视网膜血管阻塞的病例。
Case Rep Ophthalmol. 2021 May 7;12(2):344-349. doi: 10.1159/000513484. eCollection 2021 May-Aug.
6
Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.通过稳定抑制DKC1生成先天性角化不良样造血干细胞。
Stem Cell Res Ther. 2021 Jan 29;12(1):92. doi: 10.1186/s13287-021-02145-8.
7
Telomerase and CD4 T Cell Immunity in Cancer.癌症中的端粒酶与CD4 T细胞免疫
Cancers (Basel). 2020 Jun 25;12(6):1687. doi: 10.3390/cancers12061687.
8
Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations.参与端粒维持的核蛋白 CST/庇护素复合物的结构特征及其与疾病突变的关联。
Cells. 2020 Feb 4;9(2):359. doi: 10.3390/cells9020359.
9
The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy.在端粒病的诱导多能干细胞模型中,端粒酶复合物直接控制造血干细胞的分化和衰老。
Front Genet. 2018 Aug 29;9:345. doi: 10.3389/fgene.2018.00345. eCollection 2018.
10
Dysfunctional telomeres and hematological disorders.功能失调的端粒与血液系统疾病。
Differentiation. 2018 Mar-Apr;100:1-11. doi: 10.1016/j.diff.2018.01.001. Epub 2018 Jan 4.

本文引用的文献

1
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.常染色体隐性先天性角化不良和霍耶拉尔-赫雷戴松综合征中的端粒酶逆转录酶纯合突变。
Blood. 2007 Dec 15;110(13):4198-205. doi: 10.1182/blood-2006-12-062851. Epub 2007 Sep 4.
2
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.常染色体隐性遗传性先天性角化不良中的遗传异质性,其中一种亚型由端粒酶相关蛋白NOP10突变引起。
Hum Mol Genet. 2007 Jul 1;16(13):1619-29. doi: 10.1093/hmg/ddm111. Epub 2007 May 16.
3
Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.端粒功能障碍会引发环境改变,限制造血干细胞的功能和植入。
Nat Med. 2007 Jun;13(6):742-7. doi: 10.1038/nm1578. Epub 2007 May 7.
4
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.通过流式荧光原位杂交检测到的极短端粒长度可识别先天性角化不良患者。
Blood. 2007 Sep 1;110(5):1439-47. doi: 10.1182/blood-2007-02-075598. Epub 2007 Apr 27.
5
Flow cytometry and FISH to measure the average length of telomeres (flow FISH).采用流式细胞术和荧光原位杂交技术来测量端粒的平均长度(流式荧光原位杂交技术)。
Nat Protoc. 2006;1(5):2365-76. doi: 10.1038/nprot.2006.263.
6
Stem cell collection and gene transfer in Fanconi anemia.范可尼贫血中的干细胞采集与基因转移
Mol Ther. 2007 Jan;15(1):211-9. doi: 10.1038/sj.mt.6300033.
7
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.端粒酶RNA水平限制X连锁先天性角化不良中端粒的维持。
Genes Dev. 2006 Oct 15;20(20):2848-58. doi: 10.1101/gad.1476206. Epub 2006 Oct 2.
8
The biogenesis and regulation of telomerase holoenzymes.端粒酶全酶的生物合成与调控
Nat Rev Mol Cell Biol. 2006 Jul;7(7):484-94. doi: 10.1038/nrm1961.
9
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.再生障碍性贫血或骨髓增生异常综合征患儿中端粒酶RNA突变的低发生率。
J Pediatr Hematol Oncol. 2006 Jul;28(7):450-3. doi: 10.1097/01.mph.0000212952.58597.84.
10
Dyskeratosis congenita.先天性角化不良
Semin Hematol. 2006 Jul;43(3):157-66. doi: 10.1053/j.seminhematol.2006.04.001.